What Pending Legislation Could Have an Impact on Specialty Pharmacy?




At the 2018 National Association of Specialty Pharmacy (NASP) Annual Meeting and Educational Conference, Ron Lanton III, Esq., executive director and senior counsel for Frier Levitt Government Affairs, discussed several pieces of legislation in Congress that could impact specialty pharmacy. 

Transcript 

What are some helpful things in Congress right now that could affect or actually help impact specialty pharmacy? There are quite a few. I think first before we start with the answer I think it’s key to look at the legislative calendar. We’re here at September, the end of September, and we know November elections are coming up. So, basically what this means is that the things that were still percolating in Congress right now may not get carried over to the next session. The ones that don’t clear have to be reintroduced, get a new bill number, that kind of thing. But I think the things that I’m about to talk about will likely be reintroduced because they are very good issues, they have a lot of support, and hopefully they do get out before the November elections and this session ends.
 
The couple bills are: first Maximum Allowable Cost (MAC), there’s a bill over there right now addressing MAC transparency which is good on a federal level, because I know we’ve been helping clients fight things on a state-by-state level and trying to get some bills introduced on a state-by-state level. There’s Any Willing Provider for pharmacists and for Medicare Part D if there’s any kind of medically underserved areas. Most importantly, there’s a bill on DIR, which I know a lot of specialty pharmacies will be very interested in because that is something that’s taking a toll on profitability so that’ll be good to go away. Provider Status is a good one. Provider status for pharmacies that are actually able to be recognized for the services that they offer, the very valuable services that they offer, that will be good, so that’s definitely there. Those are a few things that I think will help specialty pharmacy, if enacted, so we just hope that politics are put aside and they do the right thing and hurry these bills through. 

Most Popular

Related Articles

The benefits of adopting blockchain technology have not been overlooked by the health care industry and can have a direct and lasting impact on specialty pharmacy.
Mike Agostino, RPh, President of the National Association of Specialty Pharmacy (NASP), discusses how NASP has grown to meet the evolving needs of the pharmacy profession.
Top news of the week from Specialty Pharmacy Times.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$